Distinct microbial signatures in brain tumors vary by type and location, indicating the need for tailored therapies, ref: Gigi doi.org/10.1038/s43018-025-01073-3/
Oligomeric cystatin C enhances immunosuppressive activity in myeloid cells, suggesting mechanisms of immune evasion in tumors, ref: Zhang doi.org/10.1038/s41392-025-02462-x/
Microbubble-enhanced transcranial focused ultrasound shows promise for localized drug delivery in high-grade glioma, ref: Woodworth doi.org/10.1016/S1470-2045(25)00492-9/
Cerebrospinal fluid metabolomics identifies novel biomarkers for lung cancer leptomeningeal metastasis, enhancing diagnostic capabilities, ref: Yang doi.org/10.1093/neuonc/
Patient-centric approaches improve stroke risk screening in sickle cell anemia, demonstrating the effectiveness of targeted interventions, ref: Schlenz doi.org/10.1186/s13012-025-01462-3/
Enozertinib shows promise as a brain-penetrant EGFR inhibitor for NSCLC with atypical mutations, addressing unmet needs in treatment, ref: Junttila doi.org/10.1158/0008-5472.CAN-25-3502/